About CCBR Czech Prague, s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Takeda
2
Celgene
1
Ironwood Pharmaceuticals, Inc.
1
Clinical Trials at CCBR Czech Prague, s.r.o.
During the past decade, CCBR Czech Prague, s.r.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
2014-08-26
2017-06-01
Completed
650
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
2016-01-04
2019-08-06
Completed
644
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
2016-04-15
2023-05-06
Active, not recruiting
746
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
2017-07-19
2019-02-25
Terminated
242
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis
2021-05-14
2022-11-09
Completed
214
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR Czech Prague, s.r.o."
#1 collaborator was "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at CCBR Czech Prague, s.r.o.
According to Clinical.Site data, the most researched conditions in "CCBR Czech Prague, s.r.o." are
"Cardiovascular Disease" (2 trials), "Crohn's Disease" (2 trials), "Chronic Kidney Disease (CKD)" (1 trials), "Colitis, Ulcerative" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "CCBR Czech Prague, s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at CCBR Czech Prague, s.r.o.
Most popular intervention types in "CCBR Czech Prague, s.r.o." are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "CC-93538" (1 trials), "Infliximab" (1 trials) and "Lesinurad" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CCBR Czech Prague, s.r.o.
The vast majority of trials in "CCBR Czech Prague, s.r.o." are
7 trials for "All" genders.
Clinical Trials Status at CCBR Czech Prague, s.r.o.
Currently, there are NaN active trials in "CCBR Czech Prague, s.r.o.".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in CCBR Czech Prague, s.r.o.,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in CCBR Czech Prague, s.r.o., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".